Ho Chul Shin

Title: Inventor Ho Chul Shin: A Pioneer in Pharmaceutical Composition

Introduction

Ho Chul Shin is an innovative inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance the stability of critical proteins.

Latest Patents

Ho Chul Shin holds a patent for a pharmaceutical composition with improved stability that contains a Factor VII fusion protein. This invention provides a pharmaceutical composition that includes a fusion protein comprising Factor VII (FVII) and transferrin as active ingredients. The transferrin is linked to the C-terminus of the FVII, along with trehalose or glycine as bulking agents. The composition allows for stable storage of FVII and its variants at room temperature for extended periods, making it a valuable therapeutic option for patients with hemophilia or congenital FVII deficiency.

Career Highlights

Shin currently works at Tiumbio Co., Ltd., where he continues to advance his research and development in pharmaceutical innovations. His work is instrumental in creating more effective treatments for blood disorders, showcasing his commitment to improving patient care and outcomes.

Collaborations

Ho Chul Shin collaborates with esteemed colleagues such as Hong-Kee Kim and Yoon-Jung Lee at Tiumbio Co., Ltd. Their joint efforts in research not only pave the way for new therapeutic options but also enhance the overall impact of their work in the field of biotechnology.

Conclusion

In conclusion, Ho Chul Shin is a forward-thinking inventor whose contributions to pharmaceutical compositions have the potential to greatly benefit patients suffering from various blood disorders. His dedication to innovation in stability-enhancing compositions demonstrates the importance of research in developing effective treatments in the healthcare sector.